Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Puja Khanna, MD, MPH (she/her/hers)

University of Michigan
Ann Arbor, Michigan, United States

I am a board-certified rheumatologist and
Professor of Medicine at the University of Michigan. I have a MPH degree with a focus in epidemiology and health services research. I am dually appointed at
the University of Michigan and Ann Arbor VA and have held the ACR-RRF CIFA to assess quality of life in patients with gout and evaluate gaps in treatment and knowledge. I served as a Co-I for the NIH/NIAMS PROMIS effort to develop and validate the SSc GI-Symptoms Scale. I have been involved with development of gout guidelines and quality measures at national (ACR) and international level (EULAR), G-CAN and OMERACT including the 2012 and 2020 ACR gout guidelines. My current initiatives are directed towards enhancing health outcomes for patients with rheumatic diseases (Gout, RA, SSc, AOSD among others). I have served as PI on several clinical trials including acute and chronic therapeutic agents such as sodium bicarbonate, anakinra, febuxostat, lesinurad, pegloticase, pegadricase and now, NLRP3 and URAT-1 inhibition. I have successfully studied the effect of mycophenolate mofetil in reducing immunogenicity of pegloticase in severe tophaceous gout. A longstanding interest in PRO research has helped me garner focused expertise in this field where I strive to positively impact patient lives. I developed a patient-centric educational platform, MyGoutCare, to serve as a readily available resource for patients with gout (elbow support) at Michigan Medicine.

Presentation(s):